Neuvivo, Inc. funding
Neuvivo, Inc., a pharmaceuticals company based in Palo Alto, CA, filed a Form D with the SEC on November 13, 2026 and reported $1.4M raised of a $9.5M offering.
Amount raised$1.4M
Offering size$9.5M
Filed with the SECNovember 13, 2026
First saleOctober 30, 2026
IndustryPharmaceuticals
SecuritiesEquity, Options or warrants, Security to be acquired on exercise
LocationPalo Alto, CA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far1
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Nov 13
Other health care rounds in California
BigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyEstuary Biotherapeutics, Inc.$40.7M · Oct 16BiotechnologyTrellis Bioscience, Inc.$22.9M · Oct 21BiotechnologyAdela, Inc.$12M · Oct 19BiotechnologyTempest Therapeutics, Inc.$7.5M · Oct 14BiotechnologyAbvc Biopharma, Inc.$3.4M · Nov 10BiotechnologyGale Force Aesthetics, Inc.$800K · Oct 22Other Health CareTheravie Pharma, Inc.$750K · Oct 19Biotechnology